Scopolamine and benzodiazepine models of dementia: cross-reversals by Ro 15-1788 and physostigmine
- 作者G. C. Preston; C. Ward; C. R. Lines; P. Poppleton; J. R. M. Haigh; M. Traub
- 卷第98卷
- 期第4期
- 印刷ISSN0033-3158
- 电子ISSN1432-2072
- 文件大小877.50KB
- 发表时间1989-08
- DOI10.1007/bf00441947
- 页码487-494
Chronic clozapine treatment down-regulates serotonin 5-HT-1c receptors in rat brainHietala, Jarmo; Koulu, Markku; Kuoppamäki, Mikko; Lappalainen, Jaakko; Syvälahti, Erkka · 1992
Effects of chronic SCH 23390 treatment on dopamine autoreceptor function in rat brainJaakko Lappalainen; Jarmo Hietala; Birgitta Sjöholm; Erkka Syvälahti · 1990
Ethanol administration does not alter dopamine D1 and D2 receptor characteristics in rat brainHietala, Jarmo; Salonen, Iiris; Lappalainen, Jaakko; Syvälahti, Erkka · 1990
Dopamine D1 receptor antagonism in schizophrenia: Is there reduced risk of extrapyramidal side-effects?Jarmo Hietala; Jaakko Lappalainen; Markku Koulu; Erkka Syvälahti · 1990
Regulation of dopamine D1 receptors by chronic administration of structurally different D1 receptor antagonist: A quantitative autoradiographic studyJaakko Lappalainen; Jarmo Hietala; Tiina Pohjalainen; Erkka Syvälahti · 1992
Chronic treatment with SCH 23390, a selective dopamine D-1 receptor antagonist, decreases dopamine metabolism in rat caudate nucleusMarkku Koulu; Jaakko Lappalainen; Ullamari Pesonen; Jarmo Hietala; Erkka Syvälahti · 1988